Shares of Moderna Inc. MRNA,
slipped 2.03% to $ 112.75 on Friday, on a positive stock market testing session, with the NASDAQ Composite Index COMP,
rising 1.03% to 13,201.98 and Dow Jones industrial average DJIA,
rising 0.18% to 31,097.97. This was the second day in a row of a loss. Moderna Inc. closed. $ 65.75 below its 52-week high ($ 178.50), which the company reached on Dec. 1.
The stock did not fare well compared to some of its competitors on Friday, such as AbbVie Inc. ABBV,
rose 0.52% to $ 107.27, Amgen Inc. AMGN,
rose 1.91% to $ 238.49, and AstraZeneca PLC ADR AZN,
rose 1.33% to $ 50.86. Trade volume (12.3 M) remained 13.6 million lower than the 50-day average volume of 25.9 M.
Editor’s Note: This story was automatically created by Automated Insights using data from Dow Jones and FactSet. See our Market Data Terms of Use.